Cutis laxa (CL) syndromes are connective tissue disorders characterized by redundant, sagging, inelastic and wrinkled skin, with organ involvement. Here, we describe a patient with ALDH18A1-related CL who developed cyclic vomiting. The patient was a 12-year-old boy who presented with poor postnatal growth, hypotonia, short stature, joint hyperlaxity, microcephaly, strabismus, bilateral cataracts, facial dysmorphism and severe mental retardation. Bone radiographs showed osteopenia and osteoporosis, and magnetic resonance angiography showed marked kinking and tortuosity of the brain vessels. These findings were clinically compatible with ALDH18A1-related CL. Molecular analysis revealed a de novo heterozygous mutation (p.R138Q) in ALDH18A1. No mutations were found in PYCR1 gene. The patient developed cyclic vomiting with decreased blood levels of ornithine, citrulline, arginine and proline without hyperammonemia and other hypoaminoacidemias were also found. ALDH18A1 encodes Δ(1)-pyrroline-5-carboxylate synthase, which is related to the biosynthesis of ornithine, citrulline, arginine, and proline. Cyclic vomiting has never been reported in other ALDH18A1-related CL patients. This is the first case report of ALDH18A1-related CL with cyclic vomiting associated with amino acid abnormalities.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.braindev.2016.01.003DOI Listing

Publication Analysis

Top Keywords

cyclic vomiting
20
cutis laxa
8
developed cyclic
8
ornithine citrulline
8
citrulline arginine
8
arginine proline
8
aldh18a1-related
5
cyclic
5
vomiting
5
aldh18a1-related cutis
4

Similar Publications

Landscape of Cyclic Vomiting Syndrome: From Bedside to Bench, Past to Present.

Neurogastroenterol Motil

January 2025

Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.

Investigations into mechanisms of cyclic(al) vomiting syndrome (CVS) began at the bedside more than a century ago. The modern era started with the formation of the Cyclic Vomiting Syndrome Association in 1993 that helped initiate robust efforts in education, advocacy, family physician conferences, scientific symposia, dedicated clinical programs, therapeutic guidelines, and research. Even today, bedside clues continue to emerge with the recent description of cannabinoid hyperemesis syndrome (CHS) and subsequent evidence of a perturbed endocannabinoid system.

View Article and Find Full Text PDF

Background: Cannabinoid hyperemesis syndrome (CHS) is a syndrome of cyclic nausea and vomiting in the setting of chronic cannabis use. To date, only 11 cases of CHS in pregnancy have been reported.

Case Presentation: We describe two cases of uncontrolled vomiting in pregnancy due to CHS.

View Article and Find Full Text PDF

Diagnostic characteristics of pediatric cyclic vomiting syndrome.

J Pediatr Gastroenterol Nutr

December 2024

Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.

Objectives: Cyclic vomiting syndrome (CVS) remains a diagnostic challenge due to its nonspecific presentation despite consensus-based diagnostic criteria. There is a need for improved, evidence-based diagnostic criteria. We hypothesized that symptoms differ quantitatively between children with CVS versus other vomiting conditions and that current diagnostic criteria are not sufficiently sensitive for diagnosing CVS.

View Article and Find Full Text PDF

Background: Cyclic vomiting syndrome (CVS) is defined by its episodic patterning. Furthermore, CVS is associated with other episodic disorders such as migraine and epilepsy. Indeed, many of the medications that are known to be useful for prophylaxis and abortive therapy in CVS are also effective in preventing and aborting migraines and seizures.

View Article and Find Full Text PDF
Article Synopsis
  • A study was conducted to understand the symptom patterns and natural history of cyclic vomiting syndrome (CVS) in adults over a 6-month period using daily electronic diaries.
  • The research involved 93 enrolled patients, with 88 providing data; a significant number experienced CVS episodes, with a median of 0.6 episodes per month, lasting around 3 days on average.
  • The findings indicate variability in episode patterns and emphasize the need for more precise definitions and characterizations of CVS episodes for better understanding and management of the condition.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!